Organotypic human ex vivo models for coronavirus disease 2019 research and drug development

Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late 2019, intense research efforts on an unprecedented scale have focused on the study of viral entry mechanisms and adaptive immunity. While the identification of angiotensin-converting enzyme 2 (ACE2) and other...

Descripción completa

Detalles Bibliográficos
Autores principales: Youhanna, Sonia, Wright, Shane C., Lauschke, Volker M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075816/
https://www.ncbi.nlm.nih.gov/pubmed/34029832
http://dx.doi.org/10.1016/j.coph.2021.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075816/
https://www.ncbi.nlm.nih.gov/pubmed/34029832
http://dx.doi.org/10.1016/j.coph.2021.04.006

Ejemplares similares